PERSYST 13 (P13) EEG REVIEW AND ANALYSIS SOFTWARE— 510(k) K151929

Substantially Equivalent

Persyst Development Corporation

FDA 510(k) clearance K151929 for PERSYST 13 (P13) EEG REVIEW AND ANALYSIS SOFTWARE, Substantially Equivalent on 2015-08-12. Applicant: Persyst Development Corporation.

Clearance details

Applicant: Persyst Development Corporation
Product code: Code OMB
Advisory panel: Neurology
Date received: 2015-07-14
Decision date: 2015-08-12
Decision: Substantially Equivalent
Clearance type: Special
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.